Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2020-08-31

AUTHORS

Jong-Keun Kim, Jae-Young Park, Do Yoon Lee, Du Hyun Ro, Hyuk-Soo Han, Myung Chul Lee

ABSTRACT

PurposeThis study aimed to evaluate the optimal dosage of topical tranexamic acid (TXA) considering the efficacy and safety for controlling bleeding after total knee arthroplasty (TKA).MethodsThis prospective randomized double-blinded placebo-controlled comparative study included 325 patients scheduled to undergo TKA, who were randomly assigned to five groups based on the topical TXA injection (n = 65 per group): control; group 1, 0.5 g TXA; group 2, 1.0 g TXA; group 3, 2.0 g TXA; and group 4, 3.0 g TXA. The primary outcome was decrease in postoperative hemoglobin levels. The secondary outcomes were blood loss calculated using Good’s method, drainage volume, frequency of transfusion, and range of motion (ROM). Plasma TXA levels and complications were also evaluated.ResultsSignificant differences were noted in the decrease in hemoglobin levels between the control group and groups 2 (p = 0.0027), 3 (p = 0.005), and 4 (p = 0.001). No significant differences were shown among the experimental groups. Significant differences in total blood loss and frequency of transfusion were noted between the control group and groups 2 (p = 0.004, 0.002, respectively), 3 (p = 0.007, 0.001, respectively), and 4 (p = 0.001, 0.009, respectively) without showing significant differences among the experimental groups. With respect to drainage volume, no significant differences were observed among the groups. The serum TXA levels increased proportionally with the applied dose of topical TXA immediately and at 3 and 6 h postoperatively. Symptomatic deep vein thrombosis or pulmonary embolism was not observed in any group. Other complications related to TXA administration were not detected.ConclusionTopical application of 1.0 g or more of TXA shows significant bleeding control without a dose–response relationship. Blood TXA levels increase with the TXA dose following topical TXA application. Therefore, to prevent overdosing and reduce potential complications with ensuring the effectiveness, 1.0 g of TXA is recommended as a topical application.Level of evidenceI. More... »

PAGES

3409-3417

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00167-020-06241-9

DOI

http://dx.doi.org/10.1007/s00167-020-06241-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1130470484

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/32869124


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Topical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antifibrinolytic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthroplasty, Replacement, Knee", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Loss, Surgical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tranexamic Acid", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Orthopaedic Surgery, Hanil General Hospital, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.413646.2", 
          "name": [
            "Department of Orthopaedic Surgery, Hanil General Hospital, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Jong-Keun", 
        "id": "sg:person.012667736252.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012667736252.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "Jae-Young", 
        "id": "sg:person.015450277065.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015450277065.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Do Yoon", 
        "id": "sg:person.010324026315.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010324026315.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ro", 
        "givenName": "Du Hyun", 
        "id": "sg:person.01322222131.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322222131.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Han", 
        "givenName": "Hyuk-Soo", 
        "id": "sg:person.011234154441.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011234154441.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Myung Chul", 
        "id": "sg:person.01337220140.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00003495-199957060-00017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008076201", 
          "https://doi.org/10.2165/00003495-199957060-00017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10157-003-0254-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007234579", 
          "https://doi.org/10.1007/s10157-003-0254-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00167-012-1942-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015769187", 
          "https://doi.org/10.1007/s00167-012-1942-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00167-012-2079-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036353693", 
          "https://doi.org/10.1007/s00167-012-2079-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-08-31", 
    "datePublishedReg": "2020-08-31", 
    "description": "PurposeThis study aimed to evaluate the optimal dosage of topical tranexamic acid (TXA) considering the efficacy and safety for controlling bleeding after total knee arthroplasty (TKA).MethodsThis prospective randomized double-blinded placebo-controlled comparative study included 325 patients scheduled to undergo TKA, who were randomly assigned to five groups based on the topical TXA injection (n\u2009=\u200965 per group): control; group 1, 0.5\u00a0g TXA; group 2, 1.0\u00a0g TXA; group 3, 2.0\u00a0g TXA; and group 4, 3.0\u00a0g TXA. The primary outcome was decrease in postoperative hemoglobin levels. The secondary outcomes were blood loss calculated using Good\u2019s method, drainage volume, frequency of transfusion, and range of motion (ROM). Plasma TXA levels and complications were also evaluated.ResultsSignificant differences were noted in the decrease in hemoglobin levels between the control group and groups 2 (p\u2009=\u20090.0027), 3 (p\u2009=\u20090.005), and 4 (p\u2009=\u20090.001). No significant differences were shown among the experimental groups. Significant differences in total blood loss and frequency of transfusion were noted between the control group and groups 2 (p\u2009=\u20090.004, 0.002, respectively), 3 (p\u2009=\u20090.007, 0.001, respectively), and 4 (p\u2009=\u20090.001, 0.009, respectively) without showing significant differences among the experimental groups. With respect to drainage volume, no significant differences were observed among the groups. The serum TXA levels increased proportionally with the applied dose of topical TXA immediately and at 3 and 6\u00a0h postoperatively. Symptomatic deep vein thrombosis or pulmonary embolism was not observed in any group. Other complications related to TXA administration were not detected.ConclusionTopical application of 1.0\u00a0g or more of TXA shows significant bleeding control without a dose\u2013response relationship. Blood TXA levels increase with the TXA dose following topical TXA application. Therefore, to prevent overdosing and reduce potential complications with ensuring the effectiveness, 1.0\u00a0g of TXA is recommended as a topical application.Level of evidenceI.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00167-020-06241-9", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1104512", 
        "issn": [
          "0942-2056", 
          "1433-7347"
        ], 
        "name": "Knee Surgery, Sports Traumatology, Arthroscopy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "keywords": [
      "topical tranexamic acid", 
      "total knee arthroplasty", 
      "frequency of transfusion", 
      "range of motion", 
      "group 2", 
      "blood loss", 
      "hemoglobin levels", 
      "tranexamic acid", 
      "knee arthroplasty", 
      "control group", 
      "significant differences", 
      "topical TXA", 
      "symptomatic deep vein thrombosis", 
      "placebo-controlled comparative study", 
      "postoperative hemoglobin levels", 
      "total blood loss", 
      "deep vein thrombosis", 
      "drainage volume", 
      "dose-response relationship", 
      "experimental group", 
      "TXA injection", 
      "TXA administration", 
      "ConclusionTopical application", 
      "TXA dose", 
      "Secondary outcomes", 
      "vein thrombosis", 
      "pulmonary embolism", 
      "primary outcome", 
      "TXA application", 
      "potential complications", 
      "bleeding control", 
      "optimal dose", 
      "group 1", 
      "group 3", 
      "topical application", 
      "ResultsSignificant differences", 
      "PurposeThis study", 
      "group 4", 
      "complications", 
      "dose", 
      "transfusion", 
      "arthroplasty", 
      "optimal dosage", 
      "efficacy", 
      "outcomes", 
      "group", 
      "safety", 
      "bleeding", 
      "MethodsThis", 
      "embolism", 
      "levels", 
      "thrombosis", 
      "patients", 
      "differences", 
      "administration", 
      "study", 
      "overdosing", 
      "injection", 
      "control", 
      "best method", 
      "dosage", 
      "loss", 
      "volume", 
      "comparative study", 
      "acid", 
      "frequency", 
      "decrease", 
      "relationship", 
      "effectiveness", 
      "method", 
      "respect", 
      "range", 
      "applications", 
      "motion"
    ], 
    "name": "Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study", 
    "pagination": "3409-3417", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1130470484"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00167-020-06241-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32869124"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00167-020-06241-9", 
      "https://app.dimensions.ai/details/publication/pub.1130470484"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_838.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00167-020-06241-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00167-020-06241-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00167-020-06241-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00167-020-06241-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00167-020-06241-9'


 

This table displays all metadata directly associated to this object as RDF triples.

225 TRIPLES      21 PREDICATES      112 URIs      100 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00167-020-06241-9 schema:about N06ed832338014ff6bcdc0db5ccc16d19
2 N0e7c04e8c23a435a9ab34cde36829742
3 N394aa25dd725425d8ddbbfb185f2952f
4 N399a94d6f2bc453bb0f877fd4f2a3533
5 N53340a5dfddb464a8fbd9143ede69cd4
6 N87bdbc4022ce4615abd85968a06073be
7 Nd432bde787e04abd82249592b0371db1
8 Nd6ee069dbe854faa952ca026afdbce55
9 Nf6d3b0938fc845169682f88f7cd2b451
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author N9c45ea53aec644b38f5dec7bc5fdd723
13 schema:citation sg:pub.10.1007/s00167-012-1942-5
14 sg:pub.10.1007/s00167-012-2079-2
15 sg:pub.10.1007/s10157-003-0254-y
16 sg:pub.10.2165/00003495-199957060-00017
17 schema:datePublished 2020-08-31
18 schema:datePublishedReg 2020-08-31
19 schema:description PurposeThis study aimed to evaluate the optimal dosage of topical tranexamic acid (TXA) considering the efficacy and safety for controlling bleeding after total knee arthroplasty (TKA).MethodsThis prospective randomized double-blinded placebo-controlled comparative study included 325 patients scheduled to undergo TKA, who were randomly assigned to five groups based on the topical TXA injection (n = 65 per group): control; group 1, 0.5 g TXA; group 2, 1.0 g TXA; group 3, 2.0 g TXA; and group 4, 3.0 g TXA. The primary outcome was decrease in postoperative hemoglobin levels. The secondary outcomes were blood loss calculated using Good’s method, drainage volume, frequency of transfusion, and range of motion (ROM). Plasma TXA levels and complications were also evaluated.ResultsSignificant differences were noted in the decrease in hemoglobin levels between the control group and groups 2 (p = 0.0027), 3 (p = 0.005), and 4 (p = 0.001). No significant differences were shown among the experimental groups. Significant differences in total blood loss and frequency of transfusion were noted between the control group and groups 2 (p = 0.004, 0.002, respectively), 3 (p = 0.007, 0.001, respectively), and 4 (p = 0.001, 0.009, respectively) without showing significant differences among the experimental groups. With respect to drainage volume, no significant differences were observed among the groups. The serum TXA levels increased proportionally with the applied dose of topical TXA immediately and at 3 and 6 h postoperatively. Symptomatic deep vein thrombosis or pulmonary embolism was not observed in any group. Other complications related to TXA administration were not detected.ConclusionTopical application of 1.0 g or more of TXA shows significant bleeding control without a dose–response relationship. Blood TXA levels increase with the TXA dose following topical TXA application. Therefore, to prevent overdosing and reduce potential complications with ensuring the effectiveness, 1.0 g of TXA is recommended as a topical application.Level of evidenceI.
20 schema:genre article
21 schema:isAccessibleForFree false
22 schema:isPartOf N9748bc646e91448ead94eeb7020d650b
23 Nd4dd1bc67cd3469cb3a67cf976b3856b
24 sg:journal.1104512
25 schema:keywords ConclusionTopical application
26 MethodsThis
27 PurposeThis study
28 ResultsSignificant differences
29 Secondary outcomes
30 TXA administration
31 TXA application
32 TXA dose
33 TXA injection
34 acid
35 administration
36 applications
37 arthroplasty
38 best method
39 bleeding
40 bleeding control
41 blood loss
42 comparative study
43 complications
44 control
45 control group
46 decrease
47 deep vein thrombosis
48 differences
49 dosage
50 dose
51 dose-response relationship
52 drainage volume
53 effectiveness
54 efficacy
55 embolism
56 experimental group
57 frequency
58 frequency of transfusion
59 group
60 group 1
61 group 2
62 group 3
63 group 4
64 hemoglobin levels
65 injection
66 knee arthroplasty
67 levels
68 loss
69 method
70 motion
71 optimal dosage
72 optimal dose
73 outcomes
74 overdosing
75 patients
76 placebo-controlled comparative study
77 postoperative hemoglobin levels
78 potential complications
79 primary outcome
80 pulmonary embolism
81 range
82 range of motion
83 relationship
84 respect
85 safety
86 significant differences
87 study
88 symptomatic deep vein thrombosis
89 thrombosis
90 topical TXA
91 topical application
92 topical tranexamic acid
93 total blood loss
94 total knee arthroplasty
95 tranexamic acid
96 transfusion
97 vein thrombosis
98 volume
99 schema:name Optimal dose of topical tranexamic acid considering efficacy and safety in total knee arthroplasty: a randomized controlled study
100 schema:pagination 3409-3417
101 schema:productId N41e30765ba554e0a87992b1feac74446
102 N7167a9db97e54d1893e95e0a9aaff3a5
103 Nffe7b0b985a8456498a3f87bc069a2e1
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130470484
105 https://doi.org/10.1007/s00167-020-06241-9
106 schema:sdDatePublished 2022-09-02T16:03
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher Nde99f19cd815427ea432dd2710bd0efe
109 schema:url https://doi.org/10.1007/s00167-020-06241-9
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N06ed832338014ff6bcdc0db5ccc16d19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Postoperative Hemorrhage
115 rdf:type schema:DefinedTerm
116 N0e7c04e8c23a435a9ab34cde36829742 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Prospective Studies
118 rdf:type schema:DefinedTerm
119 N394aa25dd725425d8ddbbfb185f2952f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Administration, Topical
121 rdf:type schema:DefinedTerm
122 N399a94d6f2bc453bb0f877fd4f2a3533 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Blood Loss, Surgical
124 rdf:type schema:DefinedTerm
125 N41e30765ba554e0a87992b1feac74446 schema:name dimensions_id
126 schema:value pub.1130470484
127 rdf:type schema:PropertyValue
128 N447eea1e99f0462e9ec6b9936c2de191 rdf:first sg:person.010324026315.15
129 rdf:rest Ne4a9ef746ed44b7aafd9f605e0b2ccb0
130 N53340a5dfddb464a8fbd9143ede69cd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Administration, Intravenous
132 rdf:type schema:DefinedTerm
133 N69790b35af4c46e08896f98ec4726872 rdf:first sg:person.011234154441.74
134 rdf:rest N98b77c7d8fe04b149dac6d9127d549df
135 N7167a9db97e54d1893e95e0a9aaff3a5 schema:name doi
136 schema:value 10.1007/s00167-020-06241-9
137 rdf:type schema:PropertyValue
138 N87bdbc4022ce4615abd85968a06073be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Humans
140 rdf:type schema:DefinedTerm
141 N9748bc646e91448ead94eeb7020d650b schema:issueNumber 10
142 rdf:type schema:PublicationIssue
143 N98b77c7d8fe04b149dac6d9127d549df rdf:first sg:person.01337220140.25
144 rdf:rest rdf:nil
145 N9c45ea53aec644b38f5dec7bc5fdd723 rdf:first sg:person.012667736252.06
146 rdf:rest Ne6a0657309b34160896383ed1d1a43af
147 Nd432bde787e04abd82249592b0371db1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Arthroplasty, Replacement, Knee
149 rdf:type schema:DefinedTerm
150 Nd4dd1bc67cd3469cb3a67cf976b3856b schema:volumeNumber 29
151 rdf:type schema:PublicationVolume
152 Nd6ee069dbe854faa952ca026afdbce55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Antifibrinolytic Agents
154 rdf:type schema:DefinedTerm
155 Nde99f19cd815427ea432dd2710bd0efe schema:name Springer Nature - SN SciGraph project
156 rdf:type schema:Organization
157 Ne4a9ef746ed44b7aafd9f605e0b2ccb0 rdf:first sg:person.01322222131.16
158 rdf:rest N69790b35af4c46e08896f98ec4726872
159 Ne6a0657309b34160896383ed1d1a43af rdf:first sg:person.015450277065.96
160 rdf:rest N447eea1e99f0462e9ec6b9936c2de191
161 Nf6d3b0938fc845169682f88f7cd2b451 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Tranexamic Acid
163 rdf:type schema:DefinedTerm
164 Nffe7b0b985a8456498a3f87bc069a2e1 schema:name pubmed_id
165 schema:value 32869124
166 rdf:type schema:PropertyValue
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
171 schema:name Clinical Sciences
172 rdf:type schema:DefinedTerm
173 sg:journal.1104512 schema:issn 0942-2056
174 1433-7347
175 schema:name Knee Surgery, Sports Traumatology, Arthroscopy
176 schema:publisher Springer Nature
177 rdf:type schema:Periodical
178 sg:person.010324026315.15 schema:affiliation grid-institutes:grid.31501.36
179 schema:familyName Lee
180 schema:givenName Do Yoon
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010324026315.15
182 rdf:type schema:Person
183 sg:person.011234154441.74 schema:affiliation grid-institutes:grid.31501.36
184 schema:familyName Han
185 schema:givenName Hyuk-Soo
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011234154441.74
187 rdf:type schema:Person
188 sg:person.012667736252.06 schema:affiliation grid-institutes:grid.413646.2
189 schema:familyName Kim
190 schema:givenName Jong-Keun
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012667736252.06
192 rdf:type schema:Person
193 sg:person.01322222131.16 schema:affiliation grid-institutes:grid.31501.36
194 schema:familyName Ro
195 schema:givenName Du Hyun
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322222131.16
197 rdf:type schema:Person
198 sg:person.01337220140.25 schema:affiliation grid-institutes:grid.31501.36
199 schema:familyName Lee
200 schema:givenName Myung Chul
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337220140.25
202 rdf:type schema:Person
203 sg:person.015450277065.96 schema:affiliation grid-institutes:grid.31501.36
204 schema:familyName Park
205 schema:givenName Jae-Young
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015450277065.96
207 rdf:type schema:Person
208 sg:pub.10.1007/s00167-012-1942-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015769187
209 https://doi.org/10.1007/s00167-012-1942-5
210 rdf:type schema:CreativeWork
211 sg:pub.10.1007/s00167-012-2079-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036353693
212 https://doi.org/10.1007/s00167-012-2079-2
213 rdf:type schema:CreativeWork
214 sg:pub.10.1007/s10157-003-0254-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1007234579
215 https://doi.org/10.1007/s10157-003-0254-y
216 rdf:type schema:CreativeWork
217 sg:pub.10.2165/00003495-199957060-00017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008076201
218 https://doi.org/10.2165/00003495-199957060-00017
219 rdf:type schema:CreativeWork
220 grid-institutes:grid.31501.36 schema:alternateName Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea
221 schema:name Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, South Korea
222 rdf:type schema:Organization
223 grid-institutes:grid.413646.2 schema:alternateName Department of Orthopaedic Surgery, Hanil General Hospital, Seoul, South Korea
224 schema:name Department of Orthopaedic Surgery, Hanil General Hospital, Seoul, South Korea
225 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...